Search research articles
Contact Us
Filters
Showing results (41-50 of 91) with videos related to
Page
of 10
Sort By:
Diabetes, Obesity & Metabolism
|
October 8, 2019
Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium-glucose co-transporter-2, in people with type 2 diabetes mellitus
Hong Zhang, Xiaoxue Zhu, Xiaojiao Li, et al.
Science Progress
|
February 15, 2024
Otitis media with effusion in adults during the SARS-CoV-2 epidemic
Yu Zhang, Feifei Yang, Yanan He, et al.
Pharmacological Research
|
July 26, 2022
Inulin-type fructans change the gut microbiota and prevent the development of diabetic nephropathy
Liman Luo, Jinlan Luo, Yueting Cai, et al.
Expert Opinion on Investigational Drugs
|
December 11, 2020
Safety and pharmacokinetics of a biosimilar of denosumab (KN012): Phase 1 and bioequivalence study in healthy Chinese subjects
Hong Zhang, Cuiyun Li, Jingrui Liu, et al.
Alimentary Pharmacology & Therapeutics
|
November 29, 2020
Randomised clinical trial: safety, efficacy and pharmacokinetics of HS-10234 versus tenofovir for the treatment of chronic hepatitis B infection
Hong Zhang, Yue Hu, Min Wu, et al.
Stem Cell Research
|
September 13, 2022
Generation of an induced pluripotent stem cell lines HMSCASTi002-A from peripheral blood mononuclear cells of a 38-year-old healthy female individual
Xian Xian, Jingrui Liu, Jiamin Zhang, et al.
Frontiers in Pharmacology
|
September 7, 2021
Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, HEC30654, in Healthy Chinese Subjects
Xiaojiao Li, Lei Gao, Jingrui Liu, et al.
Journal of Clinical Laboratory Analysis
|
January 23, 2019
Seasonal influence on TORCH infection and analysis of multi-positive samples with indirect immunofluorescence assay
Lu Chen, Jingrui Liu, Lei Shi, et al.
Clinical Pharmacology in Drug Development
|
December 21, 2020
Pharmacokinetics and Safety of Chiglitazar, a Peroxisome Proliferator-Activated Receptor Pan-Agonist, in Patients < 65 and ≥ 65 Years With Type 2 Diabetes
Xiaojiao Li, Jia Yu, Min Wu, et al.
Stem Cell Research
|
September 16, 2022
Generation of an induced pluripotent stem cell lines HMSCASTi001-A from peripheral blood mononuclear cells of a 35-year-old healthy male
Zhanchi Zhang, Jingrui Liu, Jiamin Zhang, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 91) with videos related to
Sort By:
Page
of 10
Diabetes, Obesity & Metabolism
|
October 8, 2019
Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium-glucose co-transporter-2, in people with type 2 diabetes mellitus
Hong Zhang, Xiaoxue Zhu, Xiaojiao Li, et al.
Science Progress
|
February 15, 2024
Otitis media with effusion in adults during the SARS-CoV-2 epidemic
Yu Zhang, Feifei Yang, Yanan He, et al.
Pharmacological Research
|
July 26, 2022
Inulin-type fructans change the gut microbiota and prevent the development of diabetic nephropathy
Liman Luo, Jinlan Luo, Yueting Cai, et al.
Expert Opinion on Investigational Drugs
|
December 11, 2020
Safety and pharmacokinetics of a biosimilar of denosumab (KN012): Phase 1 and bioequivalence study in healthy Chinese subjects
Hong Zhang, Cuiyun Li, Jingrui Liu, et al.
Alimentary Pharmacology & Therapeutics
|
November 29, 2020
Randomised clinical trial: safety, efficacy and pharmacokinetics of HS-10234 versus tenofovir for the treatment of chronic hepatitis B infection
Hong Zhang, Yue Hu, Min Wu, et al.
Stem Cell Research
|
September 13, 2022
Generation of an induced pluripotent stem cell lines HMSCASTi002-A from peripheral blood mononuclear cells of a 38-year-old healthy female individual
Xian Xian, Jingrui Liu, Jiamin Zhang, et al.
Frontiers in Pharmacology
|
September 7, 2021
Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, HEC30654, in Healthy Chinese Subjects
Xiaojiao Li, Lei Gao, Jingrui Liu, et al.
Journal of Clinical Laboratory Analysis
|
January 23, 2019
Seasonal influence on TORCH infection and analysis of multi-positive samples with indirect immunofluorescence assay
Lu Chen, Jingrui Liu, Lei Shi, et al.
Clinical Pharmacology in Drug Development
|
December 21, 2020
Pharmacokinetics and Safety of Chiglitazar, a Peroxisome Proliferator-Activated Receptor Pan-Agonist, in Patients < 65 and ≥ 65 Years With Type 2 Diabetes
Xiaojiao Li, Jia Yu, Min Wu, et al.
Stem Cell Research
|
September 16, 2022
Generation of an induced pluripotent stem cell lines HMSCASTi001-A from peripheral blood mononuclear cells of a 35-year-old healthy male
Zhanchi Zhang, Jingrui Liu, Jiamin Zhang, et al.
Page
of 10